Ruxolitinib and Decitabine in Patients With Myeloproliferative Neoplasm in Accelerated and Blast Phase
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 2 Study of Ruxolitinib and Decitabine in Patients With Myeloproliferative Neoplasm in Accelerated and Blast Phase
Blood Adv 2020 Oct 27;4(20)5246-5256, JO Mascarenhas, RK Rampal, HE Kosiorek, R Bhave, E Hexner, ES Wang, A Gerds, CN Abboud, M Kremyanskaya, D Berenzon, O Odenike, N Farnoud, A Krishnan, RS Weinberg, E McGovern, ME Salama, V Najfeld, JS Medina-Martinez, JE Arango Ossa, MF Levine, Y Zhou, L Sandy, ML Heaney, RL Levine, RA Mesa, AC Dueck, R HoffmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.